Zilu Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zilu Zhu has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Hao Li
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, USA
2 shared publications A.‐H. Hu
1 shared publicationAshima Shukla
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
1 shared publicationBao Luo
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
1 shared publicationBrian Dizon
Microbiology, and
1 shared publicationDaisuke Kitamura
Division of Molecular Biology, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba 278-0022, Japan
1 shared publication
Latest Publications
- Open Access
- 25 November 2019
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 2 (6) , e201900506
The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response
The PI3K pathway is integral for the germinal center (GC) response. However, the contribution of protein kinase B (AKT) as a PI3K effector in GC B cells remains unknown. Here, we show that mice lacking the AKT1 and AKT2 isoforms in B cells failed to form GCs, which undermined affinity maturation and antibody production in response to immunization. Upon B-cell receptor stimulation, AKT1/2–deficient B cells showed poor survival, reduced proliferation, and impaired mitochondrial and metabolic fitness, which collectively halted GC development. By comparison,Foxo1T24Amutant, which cannot be inactivated by AKT1/2 phosphorylation and is sequestered in the nucleus, significantly enhanced antibody class switch recombination via induction of activation-induced cytidine deaminase (AID) expression. By contrast, repression of FOXO1 activity by AKT1/2 promoted IRF4-driven plasma cell differentiation. Last, we show that T-cell help via CD40, but not enforced expression of Bcl2, rescued the defective GC response in AKT1/2–deficient animals by restoring proliferative expansion and energy production. Overall, our study provides mechanistic insights into the key role of AKT and downstream pathways on B cell fate decisions during the GC response.
- 25 November 2019
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 2 (6) , e201900506
Open AccessThe AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response
The PI3K pathway is integral for the germinal center (GC) response. However, the contribution of protein kinase B (AKT) as a PI3K effector in GC B cells remains unknown. Here, we show that mice lacking the AKT1 and AKT2 isoforms in B cells failed to form GCs, which undermined affinity maturation and antibody production in response to immunization. Upon B-cell receptor stimulation, AKT1/2–deficient B cells showed poor survival, reduced proliferation, and impaired mitochondrial and metabolic fitness, which collectively halted GC development. By comparison,Foxo1T24Amutant, which cannot be inactivated by AKT1/2 phosphorylation and is sequestered in the nucleus, significantly enhanced antibody class switch recombination via induction of activation-induced cytidine deaminase (AID) expression. By contrast, repression of FOXO1 activity by AKT1/2 promoted IRF4-driven plasma cell differentiation. Last, we show that T-cell help via CD40, but not enforced expression of Bcl2, rescued the defective GC response in AKT1/2–deficient animals by restoring proliferative expansion and energy production. Overall, our study provides mechanistic insights into the key role of AKT and downstream pathways on B cell fate decisions during the GC response.
- Open Access
- 1 October 2019
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 3 (10) , 447-462
Loss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages
The FOXP1 transcription factor is expressed throughout B cell development until its extinction just prior to terminal differentiation. Foxp1 nulls die of cardiac defects at midgestation, but adult rescue via fetal liver transfer led to a strong pre–B cell block. To circumvent these limitations and to investigate FOXP1 function at later stages of B cell differentiation, we generated and analyzed floxed (F) Foxp1 alleles deleted at pro–B, transitional (T) 1, and mature B cell stages. Mb-1cre–mediated deletion of Foxp1F/F confirmed its requirement for pro–B to pre–B transition. Cd21- and Cd19cre deletion led to significant reduction of germinal center formation and a second block in differentiation at the T2/marginal zone precursor stage. T-dependent and -independent immunization of FOXP1 mutants led to reduction of Ag-specific IgM, whereas responses of class-switched Abs were unimpaired. Yet, unexpectedly, plasmablast and plasma cell numbers were significantly increased by in vitro BCR stimulation of Foxp1F/F splenic follicular B cells but rapidly lost, as they were highly prone to apoptosis. RNA sequencing, gene set enrichment analysis, and chromatin immunoprecipitation sequencing analyses revealed strong enrichment for signatures related to downregulation of immune responses, apoptosis, and germinal center biology, including direct activation of Bcl6 and downregulation of Aicda/AID, the primary effector of somatic hypermutation, and class-switch recombination. These observations support a role for FOXP1 as a direct transcriptional regulator at key steps underlying B cell development in the mouse.
- 1 October 2019
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 3 (10) , 447-462
Open AccessLoss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages
The FOXP1 transcription factor is expressed throughout B cell development until its extinction just prior to terminal differentiation. Foxp1 nulls die of cardiac defects at midgestation, but adult rescue via fetal liver transfer led to a strong pre–B cell block. To circumvent these limitations and to investigate FOXP1 function at later stages of B cell differentiation, we generated and analyzed floxed (F) Foxp1 alleles deleted at pro–B, transitional (T) 1, and mature B cell stages. Mb-1cre–mediated deletion of Foxp1F/F confirmed its requirement for pro–B to pre–B transition. Cd21- and Cd19cre deletion led to significant reduction of germinal center formation and a second block in differentiation at the T2/marginal zone precursor stage. T-dependent and -independent immunization of FOXP1 mutants led to reduction of Ag-specific IgM, whereas responses of class-switched Abs were unimpaired. Yet, unexpectedly, plasmablast and plasma cell numbers were significantly increased by in vitro BCR stimulation of Foxp1F/F splenic follicular B cells but rapidly lost, as they were highly prone to apoptosis. RNA sequencing, gene set enrichment analysis, and chromatin immunoprecipitation sequencing analyses revealed strong enrichment for signatures related to downregulation of immune responses, apoptosis, and germinal center biology, including direct activation of Bcl6 and downregulation of Aicda/AID, the primary effector of somatic hypermutation, and class-switch recombination. These observations support a role for FOXP1 as a direct transcriptional regulator at key steps underlying B cell development in the mouse.
- 1 February 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (3) , 1066-1080
Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation
During a T cell-dependent immune response, formation of the germinal center (GC) is essential for the generation of high-affinity plasma cells and memory B cells. The canonical NF-κB pathway has been implicated in the initiation of GC reaction, and defects in this pathway have been linked to immune deficiencies. The paracaspase MALT1 plays an important role in regulating NF-κB activation upon triggering of Ag receptors. Although previous studies have reported that MALT1 deficiency abrogates the GC response, the relative contribution of B cells and T cells to the defective phenotype remains unclear. We used chimeric mouse models to demonstrate that MALT1 function is required in B cells for GC formation. This role is restricted to BCR signaling where MALT1 is critical for B cell proliferation and survival. Moreover, the proapoptotic signal transmitted in the absence of MALT1 is dominant to the prosurvival effects of T cell-derived stimuli. In addition to GC B cell differentiation, MALT1 is required for plasma cell differentiation, but not mitogenic responses. Lastly, we show that ectopic expression of Bcl-2 can partially rescue the GC phenotype in MALT1-deficient animals by prolonging the lifespan of BCR-activated B cells, but plasma cell differentiation and Ab production remain defective. Thus, our data uncover previously unappreciated aspects of MALT1 function in B cells and highlight its importance in humoral immunity.
- 1 February 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (3) , 1066-1080
Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation
During a T cell-dependent immune response, formation of the germinal center (GC) is essential for the generation of high-affinity plasma cells and memory B cells. The canonical NF-κB pathway has been implicated in the initiation of GC reaction, and defects in this pathway have been linked to immune deficiencies. The paracaspase MALT1 plays an important role in regulating NF-κB activation upon triggering of Ag receptors. Although previous studies have reported that MALT1 deficiency abrogates the GC response, the relative contribution of B cells and T cells to the defective phenotype remains unclear. We used chimeric mouse models to demonstrate that MALT1 function is required in B cells for GC formation. This role is restricted to BCR signaling where MALT1 is critical for B cell proliferation and survival. Moreover, the proapoptotic signal transmitted in the absence of MALT1 is dominant to the prosurvival effects of T cell-derived stimuli. In addition to GC B cell differentiation, MALT1 is required for plasma cell differentiation, but not mitogenic responses. Lastly, we show that ectopic expression of Bcl-2 can partially rescue the GC phenotype in MALT1-deficient animals by prolonging the lifespan of BCR-activated B cells, but plasma cell differentiation and Ab production remain defective. Thus, our data uncover previously unappreciated aspects of MALT1 function in B cells and highlight its importance in humoral immunity.
- 16 June 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (26) , 9573-9578
PDK1 regulates B cell differentiation and homeostasis
Significance: Phosphatidyl inositol-3 kinase (PI3K) activity is central to B lymphocyte survival, growth, and differentiation. Recent clinical studies also indicate that inhibiting the activity of the PI3Kδ isoform will be effective in treating human B cell malignancies. Here we focus on the B cell-specific role of the Ser/Thr kinase phosphoinositide-dependent kinase 1 (PDK1), a pivotal downstream effector of PI3K signaling that is required for the activation of most members of the AGC kinase family (e.g., Akt, S6K, RSK, PKC). Using conditional gene-targeting approaches, we show that the B cell receptor and a subset of cytokine receptors require PDK1 for B cell generation in the bone marrow as well as for mature B cell survival and activation.
- 16 June 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (26) , 9573-9578
PDK1 regulates B cell differentiation and homeostasis
Significance: Phosphatidyl inositol-3 kinase (PI3K) activity is central to B lymphocyte survival, growth, and differentiation. Recent clinical studies also indicate that inhibiting the activity of the PI3Kδ isoform will be effective in treating human B cell malignancies. Here we focus on the B cell-specific role of the Ser/Thr kinase phosphoinositide-dependent kinase 1 (PDK1), a pivotal downstream effector of PI3K signaling that is required for the activation of most members of the AGC kinase family (e.g., Akt, S6K, RSK, PKC). Using conditional gene-targeting approaches, we show that the B cell receptor and a subset of cytokine receptors require PDK1 for B cell generation in the bone marrow as well as for mature B cell survival and activation.
- 1 May 2013
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 190 (9) , 4465-4469
Cutting Edge: Defective Follicular Exclusion of Apoptotic Antigens Due to Marginal Zone Macrophage Defects in Autoimmune BXD2 Mice
Marginal zone macrophages (MZMs) act as a barrier to entry of circulating apoptotic debris into the follicles of secondary lymphoid organs. In autoimmune BXD2 mice, there is a progressive reduction in the function and numbers of MZMs. Absence of MZMs results in retention of apoptotic cell (AC) debris within the marginal zone (MZ) and increased loading of AC Ags on MZ B cells and MZ-precursor (MZ-P) B cells. The MZ-P B cells are capable of translocating the AC Ags to the follicular zone and stimulating T cells. Both MZMs and MZ-P B cells from BXD2 mice express low levels of tolerogenic signals and high levels of inflammatory signals. Thus, the current study suggests a multifaceted mechanism in which MZMs maintain tolerance to apoptotic autoantigens and suppress their translocation to follicles. Lack of clearance of apoptotic debris by MZMs drives follicular Ag–transportation by MZ-P B cells to stimulate an autoimmune response.
- 1 May 2013
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 190 (9) , 4465-4469
Cutting Edge: Defective Follicular Exclusion of Apoptotic Antigens Due to Marginal Zone Macrophage Defects in Autoimmune BXD2 Mice
Marginal zone macrophages (MZMs) act as a barrier to entry of circulating apoptotic debris into the follicles of secondary lymphoid organs. In autoimmune BXD2 mice, there is a progressive reduction in the function and numbers of MZMs. Absence of MZMs results in retention of apoptotic cell (AC) debris within the marginal zone (MZ) and increased loading of AC Ags on MZ B cells and MZ-precursor (MZ-P) B cells. The MZ-P B cells are capable of translocating the AC Ags to the follicular zone and stimulating T cells. Both MZMs and MZ-P B cells from BXD2 mice express low levels of tolerogenic signals and high levels of inflammatory signals. Thus, the current study suggests a multifaceted mechanism in which MZMs maintain tolerance to apoptotic autoantigens and suppress their translocation to follicles. Lack of clearance of apoptotic debris by MZMs drives follicular Ag–transportation by MZ-P B cells to stimulate an autoimmune response.
- Open Access
- 18 March 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (14) , E1282-E1290
FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
Innate-like splenic marginal zone (MZ) and peritoneal cavity B1 B lymphocytes share critical responsibilities in humoral responses but have divergent B-cell receptor (BCR) signaling features. A discrete marker of these subsets with tyrosine-based dual regulatory potential termed “Fc receptor-like 5” (FCRL5) was investigated to explore this discrepancy. Although FCRL5 repressed the robust BCR activity that is characteristic of MZ B cells, it had no influence on antigen receptor stimulation that is blunted in peritoneal cavity-derived B1 B cells. The molecular basis for the receptor’s inhibitory function derived from recruitment of the Src homology-2 domain-containing tyrosine phosphatase 1 (SHP-1) to a cytoplasmic immunoreceptor tyrosine-based inhibitory motif. Surprisingly, mutagenesis of this docking site unearthed coactivation properties for FCRL5 that were orchestrated by independent association of the Lyn Src-family kinase with an intracellular immunoreceptor tyrosine-based activation motif-like sequence. FCRL5’s unique binary regulation directly correlated with SHP-1 and Lyn activity, which, like BCR function, differed between MZ and B1 B cells. These findings collectively imply a specialized counterregulatory role for FCRL molecules at the intersection of innate and adaptive immunity.
- 18 March 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (14) , E1282-E1290
Open AccessFCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling
Innate-like splenic marginal zone (MZ) and peritoneal cavity B1 B lymphocytes share critical responsibilities in humoral responses but have divergent B-cell receptor (BCR) signaling features. A discrete marker of these subsets with tyrosine-based dual regulatory potential termed “Fc receptor-like 5” (FCRL5) was investigated to explore this discrepancy. Although FCRL5 repressed the robust BCR activity that is characteristic of MZ B cells, it had no influence on antigen receptor stimulation that is blunted in peritoneal cavity-derived B1 B cells. The molecular basis for the receptor’s inhibitory function derived from recruitment of the Src homology-2 domain-containing tyrosine phosphatase 1 (SHP-1) to a cytoplasmic immunoreceptor tyrosine-based inhibitory motif. Surprisingly, mutagenesis of this docking site unearthed coactivation properties for FCRL5 that were orchestrated by independent association of the Lyn Src-family kinase with an intracellular immunoreceptor tyrosine-based activation motif-like sequence. FCRL5’s unique binary regulation directly correlated with SHP-1 and Lyn activity, which, like BCR function, differed between MZ and B1 B cells. These findings collectively imply a specialized counterregulatory role for FCRL molecules at the intersection of innate and adaptive immunity.
- 10 September 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (39) , 15882-15887
Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR)
Cell surface Fc receptor for IgM antibody (FcμR) is the most recently identified member among FcRs. We determined the cellular distribution of mouse FcμR and the functional consequences ofFcmrdisruption. Surface FcμR expression was restricted to B-lineage cells, from immature B to plasma cells, except for a transient down-modulation during germinal center reactions.Fcmrablation had no significant effect on overall B- and T-cell development, but led to a reduction of marginal zone B cells and an increase in splenic B1 B cells. Preimmune serum IgM in mutant mice was significantly elevated as were natural autoantibodies. When immunized with live attenuated pneumococci, mutant mice mounted robust antibody responses against phosphorylcholine, but not protein, determinants compared with wild-type mice. By contrast, upon immunization with a hapten-carrier conjugate, nitrophenyl-coupled chicken γ-globulin (NP-CGG), the mutant mice had a diminished primary IgG1 response to both NP and CGG. These findings suggest that FcμR has an important role in IgM homeostasis and regulation of humoral immune responses.
- 10 September 2012
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (39) , 15882-15887
Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR)
Cell surface Fc receptor for IgM antibody (FcμR) is the most recently identified member among FcRs. We determined the cellular distribution of mouse FcμR and the functional consequences ofFcmrdisruption. Surface FcμR expression was restricted to B-lineage cells, from immature B to plasma cells, except for a transient down-modulation during germinal center reactions.Fcmrablation had no significant effect on overall B- and T-cell development, but led to a reduction of marginal zone B cells and an increase in splenic B1 B cells. Preimmune serum IgM in mutant mice was significantly elevated as were natural autoantibodies. When immunized with live attenuated pneumococci, mutant mice mounted robust antibody responses against phosphorylcholine, but not protein, determinants compared with wild-type mice. By contrast, upon immunization with a hapten-carrier conjugate, nitrophenyl-coupled chicken γ-globulin (NP-CGG), the mutant mice had a diminished primary IgG1 response to both NP and CGG. These findings suggest that FcμR has an important role in IgM homeostasis and regulation of humoral immune responses.
Selective blockade of NF‐κB by novel mutated IκBα suppresses CD3/CD28‐induced activation of memory CD4+ T cells in asthma
Background: Nuclear factor κB (NF‐κB) overactivation plays a crucial role in T‐helper 2 (Th2)‐biased allergic airway inflammation by increased activation and decreased apoptosis of CD4+ T cells. We have shown that targeted NF‐κB suppression in dendritic cells by adenoviral gene transfer of a novel mutated inhibitor of NF‐κB (IκBα) (AdIκBαM) contributes to T‐cell tolerance, but the immunosuppressive action of AdIκBαM on memory (CD45RO+) CD4+ T cells remains enigmatic.Methods: CD45RO+ T cells from Dermatophagoides farinaei‐sensitized asthmatic patients, untransfected or transfected with AdIκBαM or AdLacZ (β‐galactosidase) for 24 h, were stimulated with anti‐CD3 (1.0 μg/ml) plus anti‐CD28 (0.5 μg/ml) monoclonal antibody for an additional 24 h. IκBαM transgene expression and NF‐κB activation were detected by polymerase chain reaction (PCR), reverse transcription‐PCR (RT‐PCR), Western blot analysis, and electrophoretic mobility shift assay. Phenotype and apoptosis were measured by flow cytometry, annexin V binding, and terminal deoxyribonucleotidyl transferase‐mediated dUTP nick end labeling analyses. Cytokine production and cell proliferation were determined using enzyme‐linked immunosorbent assay and [3H] thymidine incorporation.Results: A unique 801‐bp IκBαM cDNA and a dose‐dependent increase in IκBαM transgene expression were observed in AdIκBαM‐transfected CD45RO+ T cells. Significantly, AdIκBαM inhibited CD3/CD28‐mediated NF‐κB activation in CD45RO+ T cells, leading to evident apoptosis, reduction of eotaxin, RANTES, Th1 [interferon (IFN)‐γ and interleukin (IL)‐2], and Th2 (IL‐4, IL‐5, and IL‐13 despite a slight decrease in IL‐10) cytokines and secondary proliferative response. AdIκBαM also upregulated cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) and downregulated CD69 besides no change in CD28.Conclusion: IκBαM might be beneficial to augment memory CD4+ T‐cell tolerance through modulating B7‐CD28/CTLA‐4 co‐stimulatory pathways and NF‐κB‐dependent cytokine profiles in allergic inflammatory diseases including asthma.
Selective blockade of NF‐κB by novel mutated IκBα suppresses CD3/CD28‐induced activation of memory CD4+ T cells in asthma
Background: Nuclear factor κB (NF‐κB) overactivation plays a crucial role in T‐helper 2 (Th2)‐biased allergic airway inflammation by increased activation and decreased apoptosis of CD4+ T cells. We have shown that targeted NF‐κB suppression in dendritic cells by adenoviral gene transfer of a novel mutated inhibitor of NF‐κB (IκBα) (AdIκBαM) contributes to T‐cell tolerance, but the immunosuppressive action of AdIκBαM on memory (CD45RO+) CD4+ T cells remains enigmatic.Methods: CD45RO+ T cells from Dermatophagoides farinaei‐sensitized asthmatic patients, untransfected or transfected with AdIκBαM or AdLacZ (β‐galactosidase) for 24 h, were stimulated with anti‐CD3 (1.0 μg/ml) plus anti‐CD28 (0.5 μg/ml) monoclonal antibody for an additional 24 h. IκBαM transgene expression and NF‐κB activation were detected by polymerase chain reaction (PCR), reverse transcription‐PCR (RT‐PCR), Western blot analysis, and electrophoretic mobility shift assay. Phenotype and apoptosis were measured by flow cytometry, annexin V binding, and terminal deoxyribonucleotidyl transferase‐mediated dUTP nick end labeling analyses. Cytokine production and cell proliferation were determined using enzyme‐linked immunosorbent assay and [3H] thymidine incorporation.Results: A unique 801‐bp IκBαM cDNA and a dose‐dependent increase in IκBαM transgene expression were observed in AdIκBαM‐transfected CD45RO+ T cells. Significantly, AdIκBαM inhibited CD3/CD28‐mediated NF‐κB activation in CD45RO+ T cells, leading to evident apoptosis, reduction of eotaxin, RANTES, Th1 [interferon (IFN)‐γ and interleukin (IL)‐2], and Th2 (IL‐4, IL‐5, and IL‐13 despite a slight decrease in IL‐10) cytokines and secondary proliferative response. AdIκBαM also upregulated cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) and downregulated CD69 besides no change in CD28.Conclusion: IκBαM might be beneficial to augment memory CD4+ T‐cell tolerance through modulating B7‐CD28/CTLA‐4 co‐stimulatory pathways and NF‐κB‐dependent cytokine profiles in allergic inflammatory diseases including asthma.